MARY WHITE: Open Payments
NPI 1366938649 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 49 payments from 13 companies in 2025. Trend: 2023 $812 · 2024 $701 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $138 |
| Novo Nordisk Inc | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| Lilly USA, LLC | 4 | $58 |
| PFIZER INC. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Exact Sciences Corporation | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
Products named: Wegovy, GEMTESA, QULIPTA, VRAYLAR, SHINGRIX, MOUNJARO, BREZTRI, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
